These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26924553)

  • 1. Microfluidic enrichment for the single cell analysis of circulating tumor cells.
    Yeo T; Tan SJ; Lim CL; Lau DP; Chua YW; Krisna SS; Iyer G; Tan GS; Lim TK; Tan DS; Lim WT; Lim CT
    Sci Rep; 2016 Feb; 6():22076. PubMed ID: 26924553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells.
    Khoo BL; Warkiani ME; Tan DS; Bhagat AA; Irwin D; Lau DP; Lim AS; Lim KH; Krisna SS; Lim WT; Yap YS; Lee SC; Soo RA; Han J; Lim CT
    PLoS One; 2014; 9(7):e99409. PubMed ID: 24999991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Single Cell Gene Expression and EGFR Mutation Analysis of Circulating Tumor Cells Reveals Distinct Phenotypes in NSCLC.
    Owen S; Lo TW; Fouladdel S; Zeinali M; Keller E; Azizi E; Ramnath N; Nagrath S
    Adv Biosyst; 2020 Aug; 4(8):e2000110. PubMed ID: 32700450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
    Watanabe M; Kenmotsu H; Ko R; Wakuda K; Ono A; Imai H; Taira T; Naito T; Murakami H; Abe M; Endo M; Nakajima T; Koh Y; Takahashi T
    Cancer Sci; 2018 Aug; 109(8):2539-2548. PubMed ID: 29900633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymer nanofiber-based microchips for EGFR mutation analysis of circulating tumor cells in lung adenocarcinoma.
    Jiang W; Wang H; Cui Y; Lei Y; Wang Y; Xu D; Jiang N; Chen Y; Sun Y; Zhang Y; Cao J; Ke Z
    Int J Nanomedicine; 2018; 13():1633-1642. PubMed ID: 29588590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in
    Pailler E; Faugeroux V; Oulhen M; Mezquita L; Laporte M; Honoré A; Lecluse Y; Queffelec P; NgoCamus M; Nicotra C; Remon J; Lacroix L; Planchard D; Friboulet L; Besse B; Farace F
    Clin Cancer Res; 2019 Nov; 25(22):6671-6682. PubMed ID: 31439588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of nano-enrichment in CTC detection and the clinical significance of CTCs in non-small cell lung cancer (NSCLC) treatment.
    Wei T; Zhu D; Yang Y; Yuan G; Xie H; Shen R
    PLoS One; 2019; 14(7):e0219129. PubMed ID: 31344053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips.
    Earhart CM; Hughes CE; Gaster RS; Ooi CC; Wilson RJ; Zhou LY; Humke EW; Xu L; Wong DJ; Willingham SB; Schwartz EJ; Weissman IL; Jeffrey SS; Neal JW; Rohatgi R; Wakelee HA; Wang SX
    Lab Chip; 2014 Jan; 14(1):78-88. PubMed ID: 23969419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC-chip" for primary lung cancer.
    Kanayama M; Kuwata T; Mori M; Nemoto Y; Nishizawa N; Oyama R; Matsumiya H; Taira A; Shinohara S; Takenaka M; Yoneda K; Kuroda K; Ohnaga T; Tanaka F
    Cancer Sci; 2022 Mar; 113(3):1028-1037. PubMed ID: 34964211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial.
    Yanagita M; Redig AJ; Paweletz CP; Dahlberg SE; O'Connell A; Feeney N; Taibi M; Boucher D; Oxnard GR; Johnson BE; Costa DB; Jackman DM; Jänne PA
    Clin Cancer Res; 2016 Dec; 22(24):6010-6020. PubMed ID: 27281561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microfluidic platform for high-purity separating circulating tumor cells at the single-cell level.
    Wang K; Zhou L; Zhao S; Cheng Z; Qiu S; Lu Y; Wu Z; Abdel Wahab AHA; Mao H; Zhao J
    Talanta; 2019 Aug; 200():169-176. PubMed ID: 31036170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
    Hyun KA; Lee TY; Lee SH; Jung HI
    Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Integrated Microfluidic Chip and Its Clinical Application for Circulating Tumor Cell Isolation and Single-Cell Analysis.
    Xu M; Zhao H; Chen J; Liu W; Li E; Wang Q; Zhang L
    Cytometry A; 2020 Jan; 97(1):46-53. PubMed ID: 31595638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients.
    Breitenbuecher F; Hoffarth S; Worm K; Cortes-Incio D; Gauler TC; Köhler J; Herold T; Schmid KW; Freitag L; Kasper S; Schuler M
    PLoS One; 2014; 9(1):e85350. PubMed ID: 24465542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells.
    Warkiani ME; Khoo BL; Tan DS; Bhagat AA; Lim WT; Yap YS; Lee SC; Soo RA; Han J; Lim CT
    Analyst; 2014 Jul; 139(13):3245-55. PubMed ID: 24840240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microchip for Immunomagnetic Sorting of Circulating Tumor Cells (CTCs).
    Descamps L; Laurenceau E; Cavassila S; Payen L; Le Roy D; Deman AL
    Methods Mol Biol; 2024; 2804():91-100. PubMed ID: 38753142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidic-Based Enrichment and Retrieval of Circulating Tumor Cells for RT-PCR Analysis.
    Gogoi P; Sepehri S; Chow W; Handique K; Wang Y
    Methods Mol Biol; 2017; 1634():55-64. PubMed ID: 28819840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells predict prognosis following secondline AZD 9291 treatment in EGFR-T790M mutant non-small cell lung cancer patients.
    Yang B; Zheng D; Zeng Υ; Qin A; Gao J; Yu G
    J BUON; 2018; 23(4):1077-1081. PubMed ID: 30358214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Treatment Through Detection and Monitoring of Genetic Aberrations in Single Circulating Tumor Cells.
    Tan SJ; Yeo T; Sukhatme SA; Kong SL; Lim WT; Lim CT
    Adv Exp Med Biol; 2017; 994():255-273. PubMed ID: 28560679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
    Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
    Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.